Hubei Jumpcan Pharmaceutical unit receives GMP certificate
Jan 11 (Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>:Says wholly owned pharmaceutical unit received goods manufacture practice (GMP) certificate from Shaanxi Food and Drug Administration .Certificate issued to unit's products including troche, hard capsule and granula .Valid period is until Dec. 27, 2022.
Latest Developments forHubei Jumpcan Pharmaceutical Co Ltd
Latest Key Developments inPharmaceuticals
- Voyager Therapeutics Announces Restructured Gene Therapy Relationship With Sanofi Genzyme
- Histogenics Says Merger Agreement With Ocugen Amended To Restate “Exchange Ratio” To Be 28.7650
- Avon Lifesciences Appoints Neelam Kumar Murdia As CFO
- Theravance Biopharma and Mylan Expand YUPELRI Development and Commercialization Agreement to Include China and Adjacent Territories